Live Breaking News & Updates on Belgian Federal Holding

Stay updated with breaking news from Belgian federal holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PDC*line Pharma raises €17.5 million ($20.3M) in Series B2 financing round

Liège, Belgium and Grenoble, France, December 6, 2021 – PDC line Pharma, a clinical stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, announces today the completion of its Series B2 round of financing. The company has raised a total of €17.5 million ($20.3M) wit. ....

Walloon Region , Waals Gewest , Kyonggi Do , South Korea , Chun Yang Hyun , Aeropole Gosselies , Sangwoo Lee , Eric Halioua , Cognitive Fund , Alpha Chips Corp , Regional Investment Company Of Wallonia , Alpha Holdings , Alpha Holdings Inc , Korea Exchange , Noshaq Group , Investment Company , University Of Li , Hansongneotech Co , Shinhan Financial Group , Lg Electronics , Belgian Federal Holding , Healthcare Venture Fund , Lg Energy Solution , Korea Investment Holdings , Life Sciences , Participation Company ,

ExeVir Announces Close of US$50 million / EUR42 million Series A Financing


ExeVir Announces Close of US$50 million / EUR42 million Series A Financing
- Extends Series A with additional EUR19 million led by Fund+
- Unique llama-derived VHH72-Fc antibody (XVR011) for potential treatment and prevention of Covid-19, ready to start first-in-human trials
- XVR011 expected to be effective against SARS-Cov-2 and importantly its rapidly spreading variants and other Sarbecoviruses to emerge in the future
News provided by
Share this article
Share this article
GHENT, Belgium, March 16, 2021 /PRNewswire/ ExeVir, which is developing single domain antibody therapies providing broad protection against viral infections, today announces that it has closed its Series A financing raising a total of EUR 42 million / US$50 million. The financing was led by Fund+ with VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures and new investors SRIW, Noshaq, Vives IUF, SambrInvest, as well as several Belgian family offices. ....

France General , Waals Gewest , Region Flamande , Louvain La Neuve , Bruxelles Capitale , Michel Kazatchkine , Xavier Saelens , Prnewswire Exevir , Erica Whittaker , Caroline Thielen , Van Biervliet , Katja Rosenkranz , Exevir Bio , Torsten Mummenbrauer , Philippe Monteyne , Stef Heylen , Nico Callewaert , Investissement Federale Participatie , Belgian Federal Holding , European Life Sciences , Partner At Fund , Hasselt University , Ghent University , University Of Li , University Fund , Life Sciences ,